Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Gastric Cancer

Free Subscription 12.11.2018 8 Anticancer Res 1 Eur J Cancer 2 Eur J Surg Oncol 7 Gastrointest Endosc 1 Int J Cancer 1 Oncol Rep 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Anticancer Res

1. LUCCHETTI J, Formica V, Giuliano G, Coletta D, et al
   Case Report of a Patient with Breast Metastasis from Gastric Cancer Treated with Paclitaxel and Ramucirumab Plus Regional Hyperthermia.
   Anticancer Res. 2018;38:6561-6564.
   PubMed     Text format     Abstract available
   
   
2. KAWAKUBO E, Matsumoto T, Yoshiya K, Yamashita S, et al
   BUBR1 Insufficiency Is Correlated with eNOS Reduction Experimentally In Vitro and In Vivo, and in Gastric Cancer Tissue.
   Anticancer Res. 2018;38:6099-6106.
   PubMed     Text format     Abstract available
   
   
3. UETA K, Otowa Y, Kakeji Y, Hirashima M, et al
   PROX1 Is Associated with Cancer Progression and Prognosis in Gastric Cancer.
   Anticancer Res. 2018;38:6139-6145.
   PubMed     Text format     Abstract available
   
   
4. MIYOSHI S, Tsugawa H, Matsuzaki J, Hirata K, et al
   Inhibiting xCT Improves 5-Fluorouracil Resistance of Gastric Cancer Induced by CD44 Variant 9 Expression.
   Anticancer Res. 2018;38:6163-6170.
   PubMed     Text format     Abstract available
   
   
5. KIM HM, Jeong I, Kim HJ, Kang SK, et al
   Casein Kinase 2 Inhibitor, CX-4945, as a Potential Targeted Anticancer Agent in Gastric Cancer.
   Anticancer Res. 2018;38:6171-6180.
   PubMed     Text format     Abstract available
   
   
6. SEKINO N, Kano M, Matsumoto Y, Sakata H, et al
   The Antitumor Effects of Metformin on Gastric Cancer In Vitro and on Peritoneal Metastasis.
   Anticancer Res. 2018;38:6263-6269.
   PubMed     Text format     Abstract available
   
   
7. DE FATIMA FERREIRA BORGES DA C, DE Castro Sant' Anna C, Muniz JAPC, DA Rocha CAM, et al
   Deregulation of the SRC Family Tyrosine Kinases in Gastric Carcinogenesis in Non-human Primates.
   Anticancer Res. 2018;38:6317-6320.
   PubMed     Text format     Abstract available
   
   
8. FUKUCHI M, Mochiki E, Ishiguro T, Kumagai Y, et al
   Prognostic Significance of Conversion Surgery Following First- or Second-line Chemotherapy for Unresectable Gastric Cancer.
   Anticancer Res. 2018;38:6473-6478.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Cancer

9. SAEKI H, Oki E, Kashiwada T, Arigami T, et al
   Re-evaluation of HER2 status in patients with HER2-positive advanced or recurrent gastric cancer refractory to trastuzumab (KSCC1604).
   Eur J Cancer. 2018;105:41-49.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Surg Oncol

10. JEONG O, Jung MR, Ryu SY
    Clinicopathological features and prognostic impact of splenic hilar lymph node metastasis in proximal gastric carcinoma.
    Eur J Surg Oncol. 2018 Oct 26. pii: S0748-7983(18)31934.
    PubMed     Text format     Abstract available
    
    
11. WOHNRATH DR, Araujo RLC
    D2 lymphadenectomy for gastric cancer as an independent prognostic factor of 10-year overall survival.
    Eur J Surg Oncol. 2018 Oct 30. pii: S0748-7983(18)31984.
    PubMed     Text format     Abstract available
    
    

    
    Gastrointest Endosc

12. URAIZEE I, Hart J, Waxman I, Weber CR, et al
    Unusual gastric subepithelial tumor: primary mixed acinar-endocrine neoplasm in an anemic woman.
    Gastrointest Endosc. 2018;87:1355-1356.
    PubMed     Text format    
    
    
13. ANTONINI F, Rossetti P, Angelelli L, Macarri G, et al
    Life-threatening GI bleeding secondary to multiple gastric metastases from urothelial carcinoma of the renal pelvis.
    Gastrointest Endosc. 2018;87:1362-1363.
    PubMed     Text format    
    
    
14. IMAGAWA A, Sano N
    Gastric adenocarcinoma of the fundic gland (chief cell predominant type) with brownish pigmentation.
    Gastrointest Endosc. 2018;87:1358-1359.
    PubMed     Text format    
    
    
15. YOSHIDA M, Takizawa K, Suzuki S, Koike Y, et al
    Conventional versus traction-assisted endoscopic submucosal dissection for gastric neoplasms: a multicenter, randomized controlled trial (with video).
    Gastrointest Endosc. 2018;87:1231-1240.
    PubMed     Text format     Abstract available
    
    
16. MATSUZAKI I, Hattori M, Hirose K, Esaki M, et al
    Magnetic anchor-guided endoscopic submucosal dissection for gastric lesions (with video).
    Gastrointest Endosc. 2018;87:1576-1580.
    PubMed     Text format     Abstract available
    
    
17. CHOI YK, Ahn JY, Kim DH, Jung KW, et al
    Efficacy and safety of endoscopic submucosal dissection for gastric neoplasms in patients with compensated liver cirrhosis: a propensity score-matched case-control study.
    Gastrointest Endosc. 2018 Feb 2. pii: S0016-5107(18)30098.
    PubMed     Text format     Abstract available
    
    
18. LEE YJ, Yoon JY, Park JJ, Park SJ, et al
    Clinical outcomes and factors related to colonic perforations in patients receiving self-expandable metal stent insertion for malignant colorectal obstruction.
    Gastrointest Endosc. 2018;87:1548-1557.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

19. ZHANG H, Zhu L, Bai M, Liu Y, et al
    Exosomal circRNA derived from gastric tumor promotes white adipose browning by targeting the miR-133/PRDM16 pathway.
    Int J Cancer. 2018 Nov 9. doi: 10.1002/ijc.31977.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

20. LIN Z, Liu W, Xiao C, Fan Y, et al
    TIPE2 inhibits GC via regulation of cell proliferation, apoptosis and inflammation.
    Oncol Rep. 2018;40:1307-1316.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

21. LIN XH, Huang KH, Chuang WH, Luo JC, et al
    The long term effect of metabolic profile and microbiota status in early gastric cancer patients after subtotal gastrectomy.
    PLoS One. 2018;13:e0206930.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: